Targeting Interleukin-6 Signaling with Tocilizumab in Atherosclerosis: A Meta-Analysis of Anti-Inflammatory Effects and Plaque Stabilization. OAIJMR [Internet]. 2025 Jan. 22 [cited 2026 Aug. 20];5(1):1-14. Available from: https://hmpublisher.com/index.php/OAIJMR/article/view/686